People with bipolar disorder spend much of their lives in a fragile state of calm. Between the highs of mania and the lows of depression lies euthymia, a period in which symptoms recede and daily functioning appears restored. Yet it is precisely during these seemingly stable intervals that the risk of suicide can quietly persist. A new study published in BMC Psychiatry by psychiatrists Eylül Yeral and Filiz Kulacaoğlu set out to disentangle which psychological and metabolic factors track suicidality in euthymic patients with bipolar disorder, and the answer they found is both surprising and clinically useful: the strongest signal comes not from blood pressure, waist circumference, or cholesterol, but from how patients perceive themselves.
The research team recruited 174 euthymic patients with bipolar disorder and divided them into two equal groups of 87 participants each. One group met the diagnostic criteria for metabolic syndrome, a cluster of abnormalities including elevated triglycerides, reduced high-density lipoprotein cholesterol, increased waist circumference, raised fasting plasma glucose, and high blood pressure, defined according to the National Cholesterol Education Program Adult Treatment Panel III criteria. The other group had no metabolic syndrome. This matched design allowed the investigators to ask a question that has lingered in the literature for years: does the metabolic burden that so often accompanies bipolar disorder also shape the psychological risk of suicide?
To measure resilience, the researchers used the Resilience Scale for Adults, an instrument that treats resilience not as a single trait but as a multidimensional construct. Its components include Perception of Self, Perception of Future, Structured Style, Social Competence, Family Cohesion, and Social Resources. Suicidality was assessed with the Columbia Suicide Severity Rating Scale, a structured clinical interview that distinguishes between lifetime active suicidal ideation, the severity of ideation, the intensity of ideation, and actual suicide attempts. This separation matters, because suicidal thoughts and suicidal actions do not always share the same underlying drivers, and a study that lumps them together may miss crucial differences.
The statistical strategy was deliberately conservative. The team ran group comparisons between the metabolic syndrome and non-metabolic syndrome groups, computed correlations with correction for the false discovery rate to guard against spurious findings when many variables are tested simultaneously, and finally built binary logistic regression models to identify independent correlates of each suicidality outcome. They also checked the variance inflation factors to rule out problematic multicollinearity among predictors and considered the number of events per variable, a measure of whether the models had enough outcome events to support stable estimates. Such methodological care is essential in a field where small samples and uncorrected multiple testing have produced a tangle of inconsistent results.
The headline finding concerns Perception of Self, the resilience dimension that captures a person’s sense of self-esteem, self-efficacy, and realistic self-appraisal. Higher Perception of Self scores were independently associated with lower odds of both suicidal ideation and suicide attempt. Specifically, each unit increase in Perception of Self was linked to roughly a 13 percent reduction in the odds of suicidal ideation, with an odds ratio of 0.87 and a 95 percent confidence interval of 0.81 to 0.93, and roughly a 15 percent reduction in the odds of a suicide attempt, with an odds ratio of 0.85 and a confidence interval of 0.78 to 0.91. In other words, this single psychological dimension showed a consistent protective association across the full spectrum of suicidality, from passive thoughts to enacted behavior.
Two other findings sharpened the picture. The number of previous manic episodes was associated specifically with suicidal ideation, with each additional episode raising the odds of ideation by about 15 percent, an odds ratio of 1.15 with a confidence interval of 1.03 to 1.28. This fits a growing view that the cumulative burden of mood episodes, sometimes described as neuroprogression, may leave patients more vulnerable to suicidal thinking even when they are currently well. Meanwhile, higher Structured Style scores, which reflect a preference for organization and routine, were associated specifically with increased odds of suicide attempt, with an odds ratio of 1.21 and a confidence interval of 1.06 to 1.39. The authors report this counterintuitive association as it stands; it suggests that the different facets of resilience do not map neatly onto different facets of suicidality, and that a dimension usually considered adaptive may behave unexpectedly in this clinical context.
The metabolic results were, by contrast, strikingly null. Resilience and suicidality did not differ between patients with and without metabolic syndrome. No individual metabolic parameter, whether triglycerides, waist circumference, fasting glucose, lipid fractions, or blood pressure, correlated with resilience or suicidality after false discovery rate correction. And metabolic syndrome was not an independent correlate of suicidality at any level of analysis. Given that bipolar disorder carries a substantially elevated risk of cardiometabolic disease and that metabolic dysfunction has been hypothesized to interact with mood and suicidal behavior, this absence of association is itself informative. It suggests that, at least in euthymic patients, the psychological architecture of suicide risk is separable from metabolic health.
The authors are careful to note the limits of this conclusion. The study, they write, had limited power to detect small effects, so a subtle metabolic contribution to suicidality cannot be definitively excluded. The cross-sectional design also means that associations cannot establish causation; it remains possible, for example, that suicidal experiences erode self-perception rather than the reverse. The sample consisted of euthymic outpatients from Turkish psychiatric training and research hospitals, and generalization to other populations or to patients in acute mood episodes requires caution. The study protocol was approved by the ethics committee of the Bakirkoy Sadi Konuk Training and Research Hospital, and all participants gave written informed consent in accordance with the Declaration of Helsinki.
Even with these caveats, the clinical implications are concrete. The Columbia Suicide Severity Rating Scale is already widely used in routine practice, and the Resilience Scale for Adults is a self-report instrument that could feasibly be administered in outpatient settings. If Perception of Self proves to be a robust marker across larger and more diverse samples, clinicians could incorporate resilience profiling into suicide risk assessment for patients with bipolar disorder, identifying those whose self-perception is fragile even when mood symptoms are controlled. Such an approach would complement, not replace, the standard tracking of episode counts and mood symptoms, which the study links specifically to ideation. It would also open the door to targeted interventions, since self-perception is a dimension that psychotherapeutic work can plausibly address.
At the same time, the null metabolic findings should not lull clinicians into neglecting physical health. The researchers emphasize that metabolic monitoring remains essential for the physical wellbeing of patients with bipolar disorder, independent of any connection to suicide risk. Antipsychotic and mood-stabilizing treatments, lifestyle factors, and the illness itself all contribute to cardiometabolic risk, and screening for metabolic syndrome is a standard of care for good reasons. What this study adds is a clarification of priorities: when the question is suicide risk in a currently stable patient, the psychological dimension of resilience, and above all the patient’s perception of self, deserves a central place in the evaluation. In a disorder where suicide remains one of the leading causes of death, any accessible, measurable handle on that risk is a finding worth taking seriously.
Subject of Research: Psychological resilience, metabolic syndrome, and suicidality in euthymic bipolar disorder
Article Title: Psychological resilience and suicidality in euthymic bipolar disorder: does metabolic syndrome matter?
Article References: Yeral, E., & Kulacaoğlu, F. (2026). Psychological resilience and suicidality in euthymic bipolar disorder: does metabolic syndrome matter?. BMC Psychiatry. https://doi.org/10.1186/s12888-026-08667-w
Image Credits: AI Generated
DOI: 10.1186/s12888-026-08667-w
Keywords: bipolar disorder, metabolic syndrome, psychological resilience, suicidality, suicidal ideation, suicide attempt, euthymia, Resilience Scale for Adults, Columbia Suicide Severity Rating Scale, Perception of Self, risk factors, psychiatry
Cite Scienmag News
Glenn Wilkins. (October 10, 2026). Self-Perception Emerges as Key Resilience Signal for Suicide Risk in Bipolar Disorder. Scienmag. https://scienmag.com/self-perception-emerges-as-key-resilience-signal-for-suicide-risk-in-bipolar-disorder/
Glenn Wilkins. "Self-Perception Emerges as Key Resilience Signal for Suicide Risk in Bipolar Disorder." Scienmag, 10 October 2026, https://scienmag.com/self-perception-emerges-as-key-resilience-signal-for-suicide-risk-in-bipolar-disorder/. Accessed 10 October 2026.
Glenn Wilkins. "Self-Perception Emerges as Key Resilience Signal for Suicide Risk in Bipolar Disorder." Scienmag. October 10, 2026. https://scienmag.com/self-perception-emerges-as-key-resilience-signal-for-suicide-risk-in-bipolar-disorder/

